JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on April 14, 2004; DOI: 10.1124/jpet.104.066902


0022-3565/04/3103-1208-1215$20.00
JPET 310:1208-1215, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.104.066902v1
310/3/1208    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Benowitz, N. L.
Right arrow Articles by Jacob, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Benowitz, N. L.
Right arrow Articles by Jacob, P., III

ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION

Mentholated Cigarette Smoking Inhibits Nicotine Metabolism

Neal L. Benowitz, Brenda Herrera, and Peyton Jacob, III

Division of Clinical Pharmacology and Experimental Therapeutics, Medical Service, San Francisco General Hospital Medical Center, Departments of Medicine, Psychiatry, and Biopharmaceutical Sciences, University of California, San Francisco, California

Smoking mentholated cigarettes has been suggested to convey a greater cancer risk compared with smoking nonmentholated cigarettes. Two of the possible mechanisms by which mentholated cigarette smoking could increase risk are by increasing systemic exposure to tobacco smoke toxins and by affecting the metabolism of nicotine or tobacco smoke carcinogens. To examine these possibilities, we performed a crossover study in 14 healthy smokers, one-half of whom were African-Americans and one-half whites. Subjects were randomly assigned to smoke mentholated or nonmentholated cigarettes for 1 week, then to cross over to the other type of cigarettes for another week. Subjects were confined to a Clinical Research Center for 3 days of each week, during which time blood levels of nicotine and carbon monoxide were measured throughout the day and an intravenous infusion of deuterium-labeled nicotine and cotinine was administered to determine the rate and pathways of nicotine metabolism. The systemic intake of nicotine and carbon monoxide was, on average, not affected by mentholation of cigarettes. Mentholated cigarette smoking did significantly inhibit the metabolism of nicotine (clearance: 1289 versus 1431 ml/min, two sided, p = 0.02). Inhibition of nicotine metabolism occurred both by slower oxidative metabolism to cotinine and by slower glucuronide conjugation. Our data do not support the hypothesis that mentholated cigarette smoking results in a greater absorption of tobacco smoke toxins. Our finding of impaired metabolism of nicotine while mentholated cigarette smoking suggests that mentholated cigarette smoking enhances systemic nicotine exposure.


Received February 17, 2004; accepted April 13, 2004.

Address correspondence to: Dr. Neal L. Benowitz, Division of Clinical Pharmacology and Experimental Therapeutics, University of California, San Francisco, Box 1220, San Francisco, CA 94143-1220. E-mail: nbeno{at}itsa.ucsf.edu




This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. E. Mooney, Z.-z. Li, S. E. Murphy, P. R. Pentel, C. Le, and D. K. Hatsukami
Stability of the Nicotine Metabolite Ratio in ad Libitum and Reducing Smokers
Cancer Epidemiol. Biomarkers Prev., June 1, 2008; 17(6): 1396 - 1400.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
A. J. Alberg, J. G. Ford, and J. M. Samet
Epidemiology of Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition)
Chest, September 1, 2007; 132(3_suppl): 29S - 55S.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
S. E. Wilson, R. S. Kahn, J. Khoury, and B. P. Lanphear
The Role of Air Nicotine in Explaining Racial Differences in Cotinine Among Tobacco-Exposed Children
Chest, March 1, 2007; 131(3): 856 - 862.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
M. J. Pletcher, B. J. Hulley, T. Houston, C. I. Kiefe, N. Benowitz, and S. Sidney
Menthol Cigarettes, Smoking Cessation, Atherosclerosis, and Pulmonary Function: The Coronary Artery Risk Development in Young Adults (CARDIA) Study.
Arch Intern Med, September 25, 2006; 166(17): 1915 - 1922.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
J. Hukkanen, P. Jacob III, and N. L. Benowitz
Metabolism and Disposition Kinetics of Nicotine
Pharmacol. Rev., March 1, 2005; 57(1): 79 - 115.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.